Cargando…

Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head

The traditional Chinese medicine (TCM) Yuanshi Shengmai Chenggu Tablet is used for treating the common orthopedic disease, hormone-induced avascular necrosis of the femoral head (ANFH) in China. However, its underlying mechanism and the changes induced in the treatment of ANFH remain to be fully elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jianchun, Deng, Peng, Li, Jie, Feng, Wenjun, Chen, Jinlun, Zeng, Yirong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783452/
https://www.ncbi.nlm.nih.gov/pubmed/29207081
http://dx.doi.org/10.3892/mmr.2017.8119
_version_ 1783295280754458624
author Zeng, Jianchun
Deng, Peng
Li, Jie
Feng, Wenjun
Chen, Jinlun
Zeng, Yirong
author_facet Zeng, Jianchun
Deng, Peng
Li, Jie
Feng, Wenjun
Chen, Jinlun
Zeng, Yirong
author_sort Zeng, Jianchun
collection PubMed
description The traditional Chinese medicine (TCM) Yuanshi Shengmai Chenggu Tablet is used for treating the common orthopedic disease, hormone-induced avascular necrosis of the femoral head (ANFH) in China. However, its underlying mechanism and the changes induced in the treatment of ANFH remain to be fully elucidated. In the present study, through the use of isobaric Tag for Relative and Absolute Quantitation and multiple reaction monitoring quantifications, corticosteroid-induced femoral head necrosis and the effects of treatment with Yuanshi Shengmai Chenggu Tablet were examined. The aim was to identify serum proteins, which may be potential serum markers for the early clinical diagnosis of ANFH, and maybe used to develop more rapid and convenient detection strategies. A total of five proteins were identified, comprising Ig mu chain C region, keratin, type I cytoskeletal 9, properdin, apolipoprotein A-IV, and IQ and AAA domain-containing protein 1. The expression levels of all five proteins were lower in ANFH and were higher following TCM treatment. These findings were confirmed using ELISA and western blot analysis.
format Online
Article
Text
id pubmed-5783452
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-57834522018-02-05 Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head Zeng, Jianchun Deng, Peng Li, Jie Feng, Wenjun Chen, Jinlun Zeng, Yirong Mol Med Rep Articles The traditional Chinese medicine (TCM) Yuanshi Shengmai Chenggu Tablet is used for treating the common orthopedic disease, hormone-induced avascular necrosis of the femoral head (ANFH) in China. However, its underlying mechanism and the changes induced in the treatment of ANFH remain to be fully elucidated. In the present study, through the use of isobaric Tag for Relative and Absolute Quantitation and multiple reaction monitoring quantifications, corticosteroid-induced femoral head necrosis and the effects of treatment with Yuanshi Shengmai Chenggu Tablet were examined. The aim was to identify serum proteins, which may be potential serum markers for the early clinical diagnosis of ANFH, and maybe used to develop more rapid and convenient detection strategies. A total of five proteins were identified, comprising Ig mu chain C region, keratin, type I cytoskeletal 9, properdin, apolipoprotein A-IV, and IQ and AAA domain-containing protein 1. The expression levels of all five proteins were lower in ANFH and were higher following TCM treatment. These findings were confirmed using ELISA and western blot analysis. D.A. Spandidos 2018-02 2017-11-20 /pmc/articles/PMC5783452/ /pubmed/29207081 http://dx.doi.org/10.3892/mmr.2017.8119 Text en Copyright: © Zeng et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Zeng, Jianchun
Deng, Peng
Li, Jie
Feng, Wenjun
Chen, Jinlun
Zeng, Yirong
Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title_full Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title_fullStr Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title_full_unstemmed Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title_short Increased serum protein levels by Yuanshi Shengmai Chenggu Tablet in treatment of avascular osteonecrosis of the femoral head
title_sort increased serum protein levels by yuanshi shengmai chenggu tablet in treatment of avascular osteonecrosis of the femoral head
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783452/
https://www.ncbi.nlm.nih.gov/pubmed/29207081
http://dx.doi.org/10.3892/mmr.2017.8119
work_keys_str_mv AT zengjianchun increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead
AT dengpeng increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead
AT lijie increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead
AT fengwenjun increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead
AT chenjinlun increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead
AT zengyirong increasedserumproteinlevelsbyyuanshishengmaichenggutabletintreatmentofavascularosteonecrosisofthefemoralhead